[戒烟治疗:2025年的情况]
Isabelle Jacot Sadowski1, Kevin Selby2, Carole Clair2
1Département promotion de la santé et préventions, Unisanté, Centre universitaire de médecine générale et santé publique, Université de Lausanne, 1011 Lausanne.
在瑞士,吸烟正在下降,但电子烟等新的尼古丁产品正在上升,特别是在年轻人中. 锡提辛再次显示出作为一种有效的戒烟辅助剂的前景.
科学领域:
- 公共卫生 公共卫生
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
06:12Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
